U.S., Oct. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07217509) titled 'PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry' on Sept. 08.
Brief Summary: The design is a prospective, observational (non-interventional) registry for subjects with myasthenia gravis under the care of a neurology provider. Longitudinal data are collected from both subjects and their treating neurology provider during routine clinical encounters using a structured and standardized data collection method. Approximately 1,500 myasthenia gravis subjects with no defined upper limit and 50 clinical neurology sites will be recruited.
Study Start Date: Aug. 14
Study Type: OBSERVATIONAL
Condition:
Myast...